Forget Teva: This Dividend Top Dog Is the Real Value Buy Today

2026-03-04 14:07:00 ET

Change is exciting, and it comes with risks. This is why turnaround stocks are so interesting. Right now, Teva Pharmaceutical Industries (NYSE: TEVA) is a turnaround story that may appeal to investors. But if you like dividends, you'll probably prefer this drug competitor and its lofty 6.3% yield. Here's why.

Teva doesn't currently pay a dividend, so it is hard for it to compete with any company that does if income is a key investment goal. That said, the S&P 500 index has a 1.1% yield today. The average pharmaceutical stock yields around 1.7%. And then there are drug giants like Pfizer (NYSE: PFE) , which has a yield of 6.3%. But a high yield alone isn't enough to make a stock worth buying.

Image source: Getty Images.

Continue reading